Q&A on article 10 of the MDR and IVDR
In our November newsletter, we have reported that the Commission published a Q&A document on article 10a of Regulations (EU) 2017/745 and 2017/746 (MDR and IVDR) on the obligation of economic operators to alert competent authorities and the market in the case of interruption or discontinuation of the supply chain for certain devices. Revision 1 from December 2024, provides updates to certain footnotes. You can download the document from our library section.
MDCG 2022-3
The Medical Device Coordination Group (MDCG) updated its guidance document on Verification of manufactured class D IVDs by notified bodies. The overall purpose of the document was to provide “[…] best practices for notified bodies in performing conformity assessment procedures relating to the verification of manufactured class D IVDs.” The latter is required in the context of batch testing for class D IVD medical devices under the IVDR. Revision 1 now includes a number of editorial and clarification changes that are listed on page 2 of the document. You can download the document here.
MDCG 2023-3
Rather shortly after its first revision in October last year, the MDCG has published the second revision of MDCG 2023-3, Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 and Regulation (EU) 2017/746. As the tile says, the document works as a guidance on how to handle vigilance related questions under the MDR and IVDR. This update provides minor editorial notes and corrections. You can download the document from our library section.
TEAM-NB guidance on the MDR certification process
Notified body association TEAM-NB set up a position paper on the MDR certification process including pre-application, application and post-application phases. The document is useful for all economic operators to understand as it sheds light on the complex certification process under the MDR. The document may be downloaded here.
Source: European Commission, TEAM-NB